These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 709377)

  • 21. The Design and Evaluation of an l-Dopa-Lazabemide Prodrug for the Treatment of Parkinson's Disease.
    Hoon M; Petzer JP; Viljoen F; Petzer A
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local cerebral glucose utilization is increased in acutely adrenalectomized rats.
    Kadekaro M; Ito M; Gross PM
    Neuroendocrinology; 1988 Apr; 47(4):329-34. PubMed ID: 3374757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dopamine and L-DOPA on survival of PC12 cells.
    Koshimura K; Tanaka J; Murakami Y; Kato Y
    J Neurosci Res; 2000 Oct; 62(1):112-9. PubMed ID: 11002293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of monoamine oxidase by substituted hydrazines.
    Tipton KF
    Biochem J; 1972 Jul; 128(4):913-9. PubMed ID: 4674124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The modification of the effect of phenelzine, phenylpropylhydrazine and aminooxyacetic acid on the content of gamma-aminobutyric acid in the rat brain by monoamine oxidase inhibitors].
    Matthies H; Popov N
    Acta Biol Med Ger; 1968; 20(3):371-8. PubMed ID: 5725428
    [No Abstract]   [Full Text] [Related]  

  • 28. The disappearance of serotonin by monoamine oxidase inhibitor insensitive agent in rat liver homogenate.
    Nagatsu T; Yagi K
    J Biochem; 1965 Sep; 58(3):302-4. PubMed ID: 5861338
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):84-9. PubMed ID: 7120131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of L-DOPA pharmacological activity by MAO inhibitors.
    Finberg JP; Sader-Mazbar O
    J Neural Transm (Vienna); 2007; 114(6):801-5. PubMed ID: 17417741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interrelations of endocrine function and LSD-25: effect of psychoactive drugs and of removal of endocrine glands on oxygen uptake in the rat.
    Sankar DV
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):321-38. PubMed ID: 4610673
    [No Abstract]   [Full Text] [Related]  

  • 32. The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
    Sagi Y; Driguès N; Youdim MB
    Br J Pharmacol; 2005 Oct; 146(4):553-60. PubMed ID: 16086033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [STUDIES ON NICOTINE. CHANGES IN CATECHLOAMINES IN RATS WITH NICOTINE-INDUCED CONVULSIONS].
    NAGAI K
    Nihon Yakurigaku Zasshi; 1963 Nov; 59():442-51. PubMed ID: 14106552
    [No Abstract]   [Full Text] [Related]  

  • 34. The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N(G)-nitro-L-arginine methyl ester administered alone or jointly with L-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats.
    Czarnecka A; Konieczny J; Lenda T; Lorenc-Koci E
    Brain Res; 2015 Nov; 1625():218-37. PubMed ID: 26319690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [L-DOPA uptake and catecholamine synthesis in the brains of rats with altered adrenocortical hormone levels].
    Shaliapina VG; Milusheva TsB
    Probl Endokrinol (Mosk); 1977; 23(4):94-9. PubMed ID: 905266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperglycemic effect of pyruvic acid phenylhydrazone.
    Bonomi U
    Diabetologia; 1967 Mar; 3(1):20-2. PubMed ID: 5620943
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of L-DOPA/carbidopa administration on the levels of L-DOPA, other amino acids and related compounds in the plasma, brain and heart of the rat.
    Diederich C; Milakofsky L; Hare TA; Hofford JM; Dadmarz M; Vogel WH
    Pharmacology; 1997 Sep; 55(3):109-16. PubMed ID: 9346399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAO activity in rat brain stem and cerebral cortex following acute and chronic treatment with L-dopa and ethanol + L-dopa.
    Renis M; Giovine A; Bertolino A
    Pharmacology; 1977; 15(5):392-9. PubMed ID: 918143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective D1 or D2 receptor blockade. Effects on brain functional responses to L-dopa.
    Ricchieri GL; Pizzolato G; Fabbri M; Ruggero S; Dam M; Battistin L
    Adv Neurol; 1993; 60():123-7. PubMed ID: 8420129
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of adrenalectomy on glucose homeostasis in rats fed a high-protein, carbohydrate-free diet.
    Foss MC; Kettelhut IC; Moreira AC; Migliorini RH
    Braz J Med Biol Res; 1987; 20(2):261-8. PubMed ID: 3690060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.